Results 11 to 20 of about 1,249 (168)
Therapeutic Advances in Medical Oncology, 2016 VIPoma is a rare neuroendocrine tumor (NET) with a high potential to develop hepatic metastases and poor prognosis. The primitive tumor is nonsymptomatic and usually localized within the pancreas. Liver metastasis drives the prognosis and induces profuse
Johann Dréanic +2 more
exaly +3 more sources
Treatment options of metastatic and nonmetastatic VIPoma: a review [PDF]
Langenbeck's Archives of Surgery, 2022 PURPOSE: VIPoma belongs to the group of neuroendocrine neoplasms. These tumours are located mostly in the pancreas and produce high levels of vasoactive intestinal peptide (VIP).
Azadeh Azizian +2 more
exaly +3 more sources
Chronic Diarrhea Secondary to Newly Diagnosed VIPoma [PDF]
Case Reports in Gastroenterology, 2019 Vasoactive intestinal polypeptide-secreting tumors (VIPoma) are a rare pancreatic neuroendocrine tumor that can cause chronic diarrhea with 1 case per 10 million people per year.
Domenico A. Farina +2 more
doaj +2 more sources
Ischemic stroke as a presenting feature of VIPoma due to MEN 1 syndrome
Indian Journal of Endocrinology and Metabolism, 2013 Introduction: Presentation of the ischemic stroke due to vasoactive intestinal peptide producing tumor (VIPoma) or Verner Morrison syndrome is rare. This is first of its kind case which we are reporting here which was later turned out to be multiple ...
Rushikesh Raviraj Maheshwari +6 more
doaj +2 more sources
VIPoma: a rare cause of diarrhea. A case report
Revista de la Facultad de Medicina, 2021 Introduction: Vasoactive intestinal peptide-secreting tumor (VIPoma) is a rare functional pancreatic neuroendocrine tumor (F-PNET) characterized by secretory diarrhea, hypokalemia, and hypochlorhydria.
Sara María Sánchez-Salazar +5 more
doaj +2 more sources
Journal of the ASEAN Federation of Endocrine Societies, 2019 INTRODUCTIONVasoactive intestinal peptide tumour or VIPoma is a rare pancreatic neuroendocrine tumour (PNET) with the incidence of 1 in 10 million population. The characteristic presentation of VIPomas are profuse diarrhoea with hypokalaemia and metabolic acidosis.
Ilham I +5 more
core +5 more sources
Diagnosis and Management of Functional Pancreatic Neuroendocrine Tumors in Children—A Systematic Review [PDF]
DiagnosticsBackground: Functional pancreatic neuroendocrine tumors (FpNETs) are extremely rare in childhood and adolescence, with an incidence of less than 0.1 per million.
Dorotea Keretić, Marko Bašković
doaj +2 more sources
Clinical Implications of Ki-67 Index, Grade and Hormonal Changes in Pancreatic Neuroendocrine Tumors: Insights Into Tumor Heterogeneity Based on Primary and Secondary Lesions. [PDF]
J Hepatobiliary Pancreat SciIn this retrospective study of metastatic and recurrent pancreatic neuroendocrine tumors, Murakami and colleagues demonstrated frequent discordance in Ki‐67 index and World Health Organization grade between primary and secondary lesions. Increased proliferation did not compromise survival, likely reflecting treatment adaptation. Rare hormonal phenotype
Murakami M +9 more
europepmc +2 more sources
Severe Idiopathic Secretory Diarrhoea With a Profound Sustained Response to Somatostatin Analogues: A Case Report. [PDF]
Case Rep Gastrointest MedBackground Chronic secretory diarrhoea is a diagnostic challenge with a broad differential and significant impact on patient’s quality of life. While common causes include microscopic colitis, bile acid diarrhoea, and laxative use, rarer aetiologies such as vasoactive intestinal peptide (VIP)–secreting neuroendocrine tumours (VIPomas) must be ...
Gandy G, Prudence AJA, Levy MT.
europepmc +2 more sources